ENVB News and Press, Enveric Biosciences Inc Com From 05/30/24

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today announced that the Com...

2024-05-20 11:54:12 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enveric Biosciences (NASDAQ: ENVB ) just reported results for the first quarter of 2024. Enveric Biosciences reported earnings per share of -61 cents. This was above the a...

2024-05-15 07:24:21 ET More on Enveric Biosciences Enveric Biosciences signs $66.5M non-binding term sheet with MindBio Therapeutics Enveric gains on out-licensing deal of new chemical entities for joint disease treatments Seeking Alpha’s Quant Rating on Enver...

Revealed seven classes of promising novel drug candidates discovered using Enveric’s Psybrary™ and PsyAI™ drug discovery and artificial intelligence (AI) platforms Launched business development campaign that resulted in the execution of seven non-binding term sheets w...

2024-05-14 09:27:54 ET More on Enveric Biosciences Enveric gains on out-licensing deal of new chemical entities for joint disease treatments Seeking Alpha’s Quant Rating on Enveric Biosciences Historical earnings data for Enveric Biosciences Financial ...

MindBio to develop the novel psilocin prodrug for neuropsychiatric indications utilizing microdosing to reduce or eliminate hallucinogenic impact of psychedelic compounds Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology com...

A look at the top 10 most actives in the United States iSun Inc. (ISUN) rose 39.1% to $0.1836 on volume of 68,543,172 shares Reborn Coffee Inc. (REBN) rose 122.5% to $3.85 on volume of 42,107,040 shares Pineapple Energy Inc. (PEGY) rose 6.9% to $0.0809 on volume of 28,629,136 shares Nik...

Biotechnology licensee expected to progress methods targeting breast and other cancers using cannabinoids in combination with chemotherapeutic drugs Enveric Biosciences, Inc (NASDAQ: ENVB), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule the...

2024-04-03 10:00:34 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...

2024-04-03 08:12:40 ET More on Pre-market losers & stocks. Emeren Group Ltd. (SOL) Q4 2023 Earnings Call Transcript Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript Mesoblast Limited 2024 Q2 - Results - Earnings Call Presentation Acorda falls 59%...